J. David Spence, MD. Opinion statement. Introduction
|
|
- Darlene Boone
- 6 years ago
- Views:
Transcription
1 New Treatment Options for Hypertension During Acute Ischemic or Hemorrhagic Stroke J. David Spence, MD Corresponding author J. David Spence, MD Stroke Prevention & Atherosclerosis Research Centre, Robarts Research Institute, 1400 Western Road, London, ON N6G 2V2, Canada. Current Treatment Options in Cardiovascular Medicine 2007, 9: Current Medicine Group LLC ISSN Copyright 2007 by Current Medicine Group LLC Opinion statement Widespread reluctance to treat hypertension during acute stroke is based on historical accounts of unfavorable outcomes of treatment that were badly done: therapies that cannot be controlled, such as sublingual nifedipine, oral or intramuscular antihypertensive drugs may drop blood pressure precipitously, leading to worsening of ischemia. Case fatality in stroke obeys a U-shaped relationship: blood pressures that are either too low or too high are associated with worse outcomes both in ischemic stroke and in intracerebral hemorrhage. Very high blood pressures should be lowered in acute stroke, and there are some circumstances in which high blood pressure must be treated despite the presence of stroke. To avoid worsening of ischemia by reduction in cerebral blood flow, it is necessary to treat high blood pressure in acute stroke with drugs that can be controlled; this usually means giving drugs by intravenous infusion; however, there is recent evidence that transdermal administration of nitrates, which can be removed if pressure is too low, is a convenient alternative that does not reduce cerebral blood flow in acute stroke. Introduction The risk of high blood pressure in stroke is U-shaped [1]; blood pressure during acute stroke should be neither too low nor too high, either in ischemic [2] or in hemorrhagic stroke [3,4 ]. However, the treatment of hypertension during acute stroke remains controversial. Most hypertension experts and stroke physicians are steeped in lore to the effect that it is normal and desirable for blood pressure to increase in the setting of acute stroke, and that lowering blood pressure during acute stroke is likely to be harmful. Those views were reviewed in 1985 by Yatsu and Zivin [5] in the do not treat side of a Controversies debate in Archives of Neurology. In the same issue, Spence and Del Maestro [6] responded in the treat piece. It seems they were not very persuasive. Since then the controversy persists [7,8], but clinical trials are finally under way [9,10]. In spite of the controversy, the evidence that blood pressure in acute stroke should be treated when it is very high, must be treated in some cases, and can be treated safely, is mounting. The change that has made the greatest difference is the advent of intravenous thrombolytics for acute stroke; lowering blood pressure in patients with acute stroke eligible for tissue plasminogen activator to achieve blood pressure below 185 mm Hg systolic and below 110 mm Hg diastolic so that tissue plasminogen activator can be given has become standard therapy [4 ]. In rare cases, strategically located infarctions can cause severe hypertension that mimics pheochromocytoma. Studies showed that lesions in the brain stem involve the nucleus of the tractus solitarii [11] or in the anterior hypothalamus [12]. In both of these animal models, there were marked elevations of plasma
2 New Treatment Options for Hypertension During Acute Ischemic or Hemorrhagic Stroke Spence 243 CBF Acute stroke Normal carotid artery, producing a stroke, is one example: it is not acceptable to leave blood pressure uncontrolled in a patient with aortic dissection on account of a stroke. Similarly, patients with acute congestive heart failure and/or myocardial ischemia cannot have severe hypertension untreated. The presence of a known berry aneurysm is another situation that mandates control of blood pressure. The real issues are the following: to what target levels should blood pressure be lowered, and by what means? Mean arterial pressure, mm Hg Figure 1. During acute stroke, autoregulation is lost and cerebral blood flow (CBF) becomes pressure passive in the ischemic zone. Compartmentalization of the brain by structures such as the falx and corpus callosum (in the carotid territory) or tentorium cerebelli (in the vertebrobasilar territory) result in local reduction of perfusion pressure as the result of high tissue pressure from worsening of cerebral edema by severe hypertension. catecholamines and plasma renin. Mazey et al. [13] reported a syndrome resembling pheochromocytoma secondary to stroke, and I have seen three such patients; two with brain stem and one with large carotid territory infarction. In such cases, and in patients with true pheochromocytoma, it may be necessary to use α blockade with phentolamine and/or phenoxybenzamine before giving intravenous β blockers because of the problem of increased blood pressure with unopposed α blockade. Similarly, patients with severe hypertension following bilateral neck dissection for cancer, or following a second endarterectomy contralateral to an earlier endarterectomy, may have a severe form of hypertension driven by sympathetic activation resulting from deafferentation of baroreceptors, which may require α blockade. Evidence that higher blood pressures in acute stroke are associated with worse outcomes was summarized by Willmot et al. [14 ] in a systematic review. Evidence from over 10,000 cases of acute stroke in which admission pressures and outcomes were reported showed that higher blood pressures were associated with higher mortality, and among survivors of stroke, with worse outcomes. Recent results from the Tinzaparin in Acute Ischaemic Stroke Trial replicate that finding [15 ]. Reasons why high pressure may be harmful in acute stroke include 1) increased cerebral edema in ischemic tissue [16 18], raising tissue pressure in compartments of the brain and thereby reducing cerebral blood flow (CBF); and 2) expansion of hematomas [14 ] in cases of intracerebral hemorrhage. In some patients with acute stroke, blood pressure cannot be left untreated. Aortic dissection that occludes both a renal artery, producing an acute severe hypertension, and at the same time occludes a subclavian or To what target level should the blood pressure be lowered? Concern about lowering pressure in acute stroke is based on reduction of CBF as pressure drops too low. This problem is aggravated in acute stroke because in the ischemic zone the autoregulation of CBF, which normally preserves CBF through a wide range of perfusion pressures, is lost [19]. CBF thus becomes pressure passive (Fig. 1), so maintenance of adequate perfusion pressure is critical. This problem is more complex than it may seem because patients with pre-existing severe hypertension and consequent thickening of cerebral arterioles have their CBF autoregulation shifted to the right [20]; therefore, they tolerate much higher pressures. For most patients, a mean arterial pressure approximately 120 mm Hg (representing pressures of ~ 160/100 or 180/90) would be on the autoregulation plateau; such pressure levels would therefore represent a reasonable target for initial lowering of blood pressure in most patients with acute stroke. The American Heart Association guidelines recommend a reduction of blood pressure by 10% to 15% [4 ]. Evidence of longstanding severe hypertension from the history, or the presence of left ventricular hypertrophy, would suggest that the patient s autoregulation curve is shifted to higher pressures. How should the blood pressure be lowered? In order to avoid a precipitous drop in pressure that could worsen cerebral ischemia, it is necessary to use treatments that can be controlled. Sublingual nifedipine, thankfully, is disappearing from emergency rooms. It should never be used because it can cause precipitous drops in blood pressure and cannot be retrieved. Sublingual is a misnomer; it is absorbed after swallowing [21]. Similarly, intramuscular drugs and oral drugs carry the risk of precipitous drops in blood pressure. Although candesartan appeared to be beneficial in acute stroke in the ACCESS (Acute Candesartan Cilexetil Therapy in Stroke Survivors) trial [22], there was no reduction in blood pressure in that study. Similar to inhibitors of angiotensinconverting enzyme, antagonists of angiotensin II receptors carry the risk of precipitous blood pressure
3 244 Cerebrovascular Disease and Stroke drop in patients with renovascular hypertension. The mechanism has been called kicking the back door out of the glomerulus [23]. I have reported that among patients with carotid stenosis and resistant hypertension, 25% have renovascular hypertension [24]. Therefore, oral angiotensin-converting enzyme inhibitors or angiotensin II receptors are not safe in patients with stroke. Thus, the management of hypertension in acute stroke requires administration of intravenous drugs by infusion. Diagnostic considerations When a patient with acute stroke has severe hypertension, it is important that the therapy initiated in the emergency room not interfere with diagnosis. Patients with resistant hypertension are much more likely to have an underlying cause of hypertension, the cause of which should be identified in order to optimize therapy. Among African-American patients with resistant hypertension, low renin hypertension is much more common [25,26]. Both primary hyperaldosteronism (usually due to bilateral hyperplasia of the adrenal cortex) [27] or a renal tubular sodium channel mutation (Liddle s syndrome and variants) [28] causing retention of salt and water are much more common in patients with African ancestors (and probably in Africans) [26]. Because β blockers suppress plasma renin, it is important to draw plasma renin and aldosterone before initiating Treatment Pharmacologic treatment Intravenous β blockers therapy with intravenous β blockers. Administration of a diuretic such as intravenous furosemide before drawing the blood samples for plasma renin and aldosterone will help, both with blood pressure control and with diagnosis [29]. Treatment of hypertension in acute stroke Current guidelines recommend treatment with intravenous β blockers, intravenous nicardipine, nitroglycerine paste, and/or sodium nitroprusside [4,30]. However, although nitroprusside apparently spares CBF [30], it is rather difficult to use. Blood pressure control is very brief, requiring minute-to-minute adjustment of dose, and both tolerance and cyanide toxicity [31,32] are problems. My own preference is for infusion of a β-adrenergic blocker, and if necessary addition of nitrate paste or patches. In more severe hypertension intravenous nitroprusside, or intravenous hydralazine (which is easier to manage because blood pressure fluctuations are not so chaotic), may be necessary. If the hypertension is very severe and difficult to control, unusual causes such as pheochromocytoma or distention of the urinary tract (eg, from ureteric stricture or inadvertent ligation of a ureter in the course of hysterectomy or other abdominal surgery) should be suspected, detected, and treated specifically. β-adrenergic blockers can be given by intravenous infusion; because their half-lives are usually hours in duration, there is a long lead time to anticipate excessive dosing and reduce the dose; heart rate can be used to guide dosing. Contraindications: Asthma, congestive heart failure. Main adverse effects: Aggravation of asthma, bradycardia, congestive heart failure. Labetalol Initial dose of 10 to 20 mg intravenously over 1 to 2 minutes, followed by an intravenous infusion at 2 to 8 mg/min [4 ]; aim for a 10% to 15% reduction in blood pressure [4 ]. Intravenous sodium nitroprusside Sodium nitroprusside is very potent but difficult to use because blood pressure lability requires constant monitoring (best by arterial line) with frequent dose adjustments. This is best reserved for very severe hypertension; American Heart Association guidelines recommend greater than 140 mm Hg for diastolic blood pressure [4 ].
4 New Treatment Options for Hypertension During Acute Ischemic or Hemorrhagic Stroke Spence 245 Contraindications: Severe aortic stenosis requires special caution [33,34]. Main drug interactions: Low serum albumin may increase toxicity. Main adverse effects: Cyanide toxicity. Sodium nitroprusside Initially, 0.5 μg/kg/min by intravenous infusion, with constant monitoring of blood pressure [4 ]; titrate dose to achieve target blood pressure (up to 8 μg/kg/min [35]); aim for a 10% to 15% reduction in blood pressure [4 ]. Intravenous hydralazine Intravenous infusion achieves smoother blood pressure control compared with nitroprusside; it is best used with intravenous β blockers, which prevent tachycardia and worsening of angina pectoris. Contraindications: Caution required in patients with angina. Main adverse effects: Tachycardia, aggravation of angina. Hydralazine 5 to 10 mg/h by intravenous infusion; titrate dose to target blood pressure; aim for a 10% to 15% reduction in blood pressure [4 ]. Intravenous calcium channel antagonists Intravenous infusion achieves smoother blood pressure control compared with nitroprusside; it is best used with intravenous β blockers, which prevent tachycardia and worsening of angina pectoris. Contraindications: Caution required in patients with angina. Main adverse effects: Tachycardia, aggravation of angina. Nicardipine 5 to 10 mg/h by infusion initially; titrate dose to target blood pressure by increasing 2.5 mg/h every 5 minutes to a maximum of 15 mg/h [4 ]; aim for a 10% to 15% reduction in blood pressure [4 ]. Emerging therapies Recently, Willmot et al. [9 ] have shown that transdermal glyceryl trinitrate (GTN) lowers blood pressure in patients with acute stroke, while maintaining CBF. Patients were randomized to receive GTN, 5-mg patch, versus control. GTN lowered peripheral systolic blood pressure by 14% systolic and 3% diastolic, with no change in heart rate, and without any reduction of CBF in either hemisphere, or in the area of stroke oligemia, penumbra, or core. Nitrate patch is convenient to use and has the important advantage that it can be removed when pressure reaches target levels [36]. Therefore, this form of therapy is likely to become more prevalent. The efficacy results of the ENOS (Efficacy of Nitric Oxide in Stroke) trial are eagerly anticipated.
5 246 Cerebrovascular Disease and Stroke References and Recommended Reading Papers of particular interest, published recently, have been highlighted as: Of importance Of major importance 1. Leonardi-Bee J, Bath PM, Phillips SJ, Sandercock PA: Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002, 33: Okumura K, Ohya Y, Maehara A, et al.: Effects of blood pressure levels on case fatality after acute stroke. J Hypertens 2005, 23: Dandapani BK, Suzuki S, Kelley RE, et al.: Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke 1995, 26: Adams H, Adams R, Del ZG, Goldstein LB: Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke 2005, 36: Consensus guidelines of the American Heart Association Stroke Council, with specific recommendations on blood pressure lowering, including targets and recommended treatments in acute stroke. 5. Yatsu FM, Zivin J: Hypertension in acute ischemic strokes. Not to treat. Arch Neurol 1985, 42: Spence JD, Del Maestro RF: Hypertension in acute ischemic strokes. Treat. Arch Neurol 1985, 42: Bath P, Chalmers J, Powers W, et al.: International Society of Hypertension (ISH): statement on the management of blood pressure in acute stroke. J Hypertens 2003, 21: Chalmers J: Blood pressure and stroke: a continuing debate. J Hypertens 2006, 24: Willmot M, Ghadami A, Whysall B, et al.: Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension 2006, 47: A randomized trial showing that transdermal GTN patches lower blood pressure in acute stroke while preserving CBF. 10. Bath PM: Major ongoing stroke trials. Efficacy of Nitric Oxide in Stroke (ENOS) trial [abstract]. Stroke 2001, 32: Doba N, Reis DJ: Acute fulminating neurogenic hypertension produced by brainstem lesions in the rat. Circ Res 1973, 32: Nathan MA, Reis DJ: Fulminating arterial hypertension with pulmonary edema from release of adrenomedullary catecholamines after lesions of the anterior hypothalamus in the rat. Circ Res 1975, 37: Mazey RM, Kotchen TA, Ernst CB: A syndrome resembling pheochromocytoma following a stroke. Report of a case. JAMA 1974, 230: Willmot M, Leonardi-Bee J, Bath PM: High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension 2004, 43: A systematic review of the consequences of high blood pressure in acute stroke. 15. Sprigg N, Gray LJ, Bath PM, et al.: Relationship between outcome and baseline blood pressure and other haemodynamic measures in acute ischaemic stroke: data from the TAIST trial. J Hypertens 2006, 24: A large clinical trial with useful evidence regarding the effects of high blood pressure on the outcome of acute stroke. 16. Halsey JH Jr, O Brien MD: Role of hypertension in pathogenesis of cerebral infarction edema. Adv Neurol 1980, 28: Hayakawa T, Waltz AG, Jacobson RL: Hypertension and acute focal cerebral ischemia. Infarction and edema after occlusion of a middle cerebral artery in cats. Stroke 1979, 10: Karki A, Westergren I, Widner H, et al.: Tirilazad reduces brain edema after middle cerebral artery ligation in hypertensive rats. Acta Neurochir Suppl (Wien) 1994, 60: Paulson OB, Lassen NA, Skinhoj E: Regional cerebral blood flow in apoplexy without arterial occlusion. Neurology 1970, 20: Strandgaard S: Autoregulation of cerebral blood flow in hypertensive patients. The modifying influence of prolonged antihypertensive treatment on the tolerance to acute, druginduced hypotension. Circulation 1976, 53: van HJ, Burggraaf K, Danhof M, et al.: Negligible sublingual absorption of nifedipine. Lancet 1987, 2: Schrader J, Luders S, Kulschewski A, et al.: The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke 2003, 34: Hackam DG, Thain LM, Abassakoor A, et al.: Trapped renal arteries: functional renal artery stenosis due to occlusion of the aorta in the arch and below the kidneys. Can J Cardiol 2001, 17: Spence JD: Management of resistant hypertension in patients with carotid stenosis: high prevalence of renovascular hypertension. Cerebrovasc Dis 2000, 10: Spence JD: Individualized therapy for hypertension. Hypertension 2006, 47:e Spence JD: Physiologic tailoring of therapy for resistant hypertension: 20 years experience with stimulated renin profiling. Am J Hypertens 1999, 12(11 Pt 1): Biglieri EG, Kater CE, Arteaga EE: Primary aldosteronism is comprised of primary adrenal hyperplasia and adenoma. J Hypertens Suppl 1984, 2:S259 S Baker EH, Duggal A, Dong Y, et al.: Amiloride, a specific drug for hypertension in black people with T594M variant? Hypertension 2002, 40: Wallach L, Nyarai I, Dawson KG: Stimulated renin: a screening test for hypertension. Ann Intern Med 1975, 82: Butterworth RJ, Cluckie A, Jackson SH, et al.: Pathophysiological assessment of nitric oxide (given as sodium nitroprusside) in acute ischaemic stroke. Cerebrovasc Dis 1998, 8: Rindone JP, Sloane EP: Cyanide toxicity from sodium nitroprusside: risks and management. Ann Pharmacother 1992, 26: Alaniz C, Watts B: Monitoring cyanide toxicity in patients receiving nitroprusside therapy. Ann Pharmacother 2005, 39: Gogbashian A: Nitroprusside in critically ill patients with aortic stenosis. N Engl J Med 2003, 349: Khot UN, Novaro GM, Popovic ZB, et al.: Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. N Engl J Med 2003, 348: Sinaiko AR: Hypertension in children. N Engl J Med 1996, 335: Spence JD: Treating hypertension in acute stroke: a better arrow for the quiver. Hypertension 2006, 47:1051.
BLOOD PRESSURE MANAGEMENT IN THE ACUTE PHASE
BLOOD PRESSURE MANAGEMENT IN THE ACUTE PHASE Ελένη Κορομπόκη, MD, PhD, FESO Α Νευρολογική Κλινική, ΕΚΠΑ, Αιγινήτειο Νοσοκομείο Κλινική Ερευνήτρια, Department of Stroke Medicine, Imperial College London,
More informationHypertensives Emergency and Urgency
Hypertensives Emergency and Urgency Budi Yuli Setianto Cardiology Divisision Department of Internal Medicine Faculty of Medicine UGM Sardjito Hospital Yogyakarta Background USA: Hypertension is 30% of
More informationBlood Pressure Management in Acute Stroke. Bradley Molyneaux, M.D., Ph.D. Departments of Neurology & Critical Care Medicine University of Pittsburgh
Blood Pressure Management in Acute Stroke Bradley Molyneaux, M.D., Ph.D. Departments of Neurology & Critical Care Medicine University of Pittsburgh 80 yo M w/ R MCA syndrome NIHSS 14 A balancing act Cerebral
More informationSection 3, Lecture 2
59-291 Section 3, Lecture 2 Diuretics: -increase in Na + excretion (naturesis) Thiazide and Related diuretics -decreased PVR due to decreases muscle contraction -an economical and effective treatment -protect
More informationManaging Hypertension in the Perioperative Arena
Managing Hypertension in the Perioperative Arena Optimizing Perioperative Management Strategies for Hypertension in the Cardiac Surgical Patient Objectives: Treatment of hypertensive emergencies. ALBERT
More informationAntihypertensive Agents Part-2. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia
Antihypertensive Agents Part-2 Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Agents that block production or action of angiotensin Angiotensin-converting
More informationHypertensive Crises. Controlling high blood pressure prevents disease. Recognition and Management of Acute Hypertensive Emergencies
Controlling high blood pressure prevents disease Recognition and Management of Acute Hypertensive Emergencies David idweiner, M.D. Co-holder, C. Craig and Audrae Tisher Chair in Nephrology Functional Genomics
More informationIntroductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs
Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs Blood Pressure Normal = sys
More informationManagement of Hypertension
Clinical Practice Guidelines Management of Hypertension Definition and classification of blood pressure levels (mmhg) Category Systolic Diastolic Normal
More informationBlood Pressure Management in Acute Ischemic Stroke
Blood Pressure Management in Acute Ischemic Stroke Kimberly Clark, PharmD, BCCCP Clinical Pharmacy Specialist Critical Care, Greenville Health System Adjunct Assistant Professor, South Carolina College
More informationIncidental Findings; Management of patients presenting with high BP. Phil Swales
Incidental Findings; Management of patients presenting with high BP Phil Swales Consultant Physician Acute & General Medicine University Hospitals of Leicester NHS Trust Objectives The approach to an incidental
More informationLab Period: Name: Physiology Chapter 14 Blood Flow and Blood Pressure, Plus Fun Review Study Guide
Lab Period: Name: Physiology Chapter 14 Blood Flow and Blood Pressure, Plus Fun Review Study Guide Main Idea: The function of the circulatory system is to maintain adequate blood flow to all tissues. Clinical
More informationAntihypertensive drugs SUMMARY Made by: Lama Shatat
Antihypertensive drugs SUMMARY Made by: Lama Shatat Diuretic Thiazide diuretics The loop diuretics Potassium-sparing Diuretics *Hydrochlorothiazide *Chlorthalidone *Furosemide *Torsemide *Bumetanide Aldosterone
More informationHYPERTENSION IN EMERGENCY MEDICINE Michael Jay Bresler, M.D., FACEP
HYPERTENSION IN EMERGENCY MEDICINE Michael Jay Bresler, M.D., FACEP What is normal blood pressure? Prehypertension 130-139/80-90 Compared with normal BP Double the risk for developing hypertension. Lifestyle
More information1. Antihypertensive agents 2. Vasodilators & treatment of angina 3. Drugs used in heart failure 4. Drugs used in arrhythmias
1. Antihypertensive agents 2. Vasodilators & treatment of angina 3. Drugs used in heart failure 4. Drugs used in arrhythmias Only need to know drugs discussed in class At the end of this section you should
More informationVA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005
VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005 1 Any adult in the health care system 2 Obtain blood pressure (BP) (Reliable,
More informationFunctional vascular disorders
Functional vascular disorders Raynaud s phenomenon Raynaud s phenomenon Refers to Intermittent,bilateral attacks of ischemia of the fingers or toes, and sometimes ears or nose. It clinically manifests
More informationRESISTENT HYPERTENSION. Dr. Helmy Bakr Professor and Head of Cardiology Dept. Mansoura University
RESISTENT HYPERTENSION Dr. Helmy Bakr Professor and Head of Cardiology Dept. Mansoura University Resistant Hypertension Blood pressure remaining above goal in spite of concurrent use of 3 antihypertensive
More informationHeart Failure (HF) Treatment
Heart Failure (HF) Treatment Heart Failure (HF) Complex, progressive disorder. The heart is unable to pump sufficient blood to meet the needs of the body. Its cardinal symptoms are dyspnea, fatigue, and
More informationAgenda. Management of Accelerated Hypertension (Updated in 2017) Salwa Roshdy Prof. of Cardiology Assiut University CardioEgypt 23/2/2017 2/27/2017
Management of Accelerated Hypertension (Updated in 2017) By Salwa Roshdy Prof. of Cardiology Assiut University CardioEgypt 23/2/2017 Agenda Definition of Accelerated HTN Pathophysiology & Etiology Prognosis
More informationCerebral Autoregulation What s the Big Deal? Kathy Morrison MSN, RN, CNRN Gayle Watson MSN, RN, CCNS, CCRN
Cerebral Autoregulation What s the Big Deal? Kathy Morrison MSN, RN, CNRN Gayle Watson MSN, RN, CCNS, CCRN Background 30% of patients have history of hypertension prior to stroke 80% will present with
More informationAntihypertensive drugs: I. Thiazide and other diuretics:
Clinical assessment of hypertensive patient: You have to take history regarding the presence of other risk factors for CAb like diabetes mellitus, smoking, etc. Take history whether the patient takes medications
More informationHypertensive Urgency and Emergency. Definitions. Emergency or Urgency?
Hypertensive Urgency and Emergency Joel Handler MD Kaiser Permanente Care Management Institute/ SCal Region Hypertension Lead Definitions Hypertensive Emergency: -Severe elevation in BP with evidence of
More informationCHAPTER 12 HYPERTENSION IN SPECIAL GROUPS HYPERTENSION IN PREGNANCY
CHAPTER 12 HYPERTENSION IN SPECIAL GROUPS HYPERTENSION IN PREGNANCY v Mild preeclampsia is managed by close observation of the mother and fetus preferably in hospital. If the diastolic blood pressure remains
More informationStroke in Pregnancy. Stroke in Pregnancy 6/23/13
G5#$#Preven*ng#Maternal#Morbidity#and#Mortality#Via# Expanded#Scope#of#Nursing#Prac*ce#As#First#Responder# in#hypertensive#crisis#of#preeclampsia# The$presenter$reports$no$relevant,$influencing$financial$rela5onships.$
More informationAntihypertensives. Antihypertensive Classes. RAAS Inhibitors. Renin-Angiotensin Cascade. Angiotensin Receptors. Approaches to Hypertension Treatment
Approaches to Hypertension Treatment Antihypertensives Inhibit Sympathetic impulses Inhibit contractility Inhibit heart rate Inhibit vasoconstriction Inhibit smooth muscle function Inhibit RAAS Inhibit
More informationProtocol for IV rtpa Treatment of Acute Ischemic Stroke
Protocol for IV rtpa Treatment of Acute Ischemic Stroke Acute stroke management is progressing very rapidly. Our team offers several options for acute stroke therapy, including endovascular therapy and
More informationHypertension (JNC-8)
Hypertension (JNC-8) Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 17, 2018, presented by Ezra Levy, Pharm.D.! The 8 th Joint
More informationM2 TEACHING UNDERSTANDING PHARMACOLOGY
M2 TEACHING UNDERSTANDING PHARMACOLOGY USING CVS SYSTEM AS AN EXAMPLE NIGEL FONG 2 JAN 2014 TODAY S OBJECTIVE Pharmacology often seems like an endless list of mechanisms and side effects to memorize. To
More informationAngina Pectoris. Edward JN Ishac, Ph.D. Smith Building, Room
Angina Pectoris Edward JN Ishac, Ph.D. Smith Building, Room 742 eishac@vcu.edu 828-2127 Department of Pharmacology and Toxicology Medical College of Virginia Campus of Virginia Commonwealth University
More informationDefinition of Congestive Heart Failure
Heart Failure Definition of Congestive Heart Failure A clinical syndrome of signs & symptoms resulting from the heart s inability to supply adequate tissue perfusion. CHF Epidemiology Affects 4.7 million
More informationCategories of HTN. Overview of Hypertension. Types of Hypertension
Categories of HTN Overview of Hypertension Normal SBP 100 Quick review of the Basics: What is
More informationCardiovascular Disorders. Heart Disorders. Diagnostic Tests for CV Function. Bio 375. Pathophysiology
Cardiovascular Disorders Bio 375 Pathophysiology Heart Disorders Heart disease is ranked as a major cause of death in the U.S. Common heart diseases include: Congenital heart defects Hypertensive heart
More informationHypertension Epidemiology 6% of deaths worldwide Defined as any of the following: systolic blood pressure 140 mmhg, diastolic blood pressure 90 mmhg, taking antihypertensive medications Pulse pressure=
More informationCoral Trials: A personal experience that challenges its results in patients with uncontrolled blood pressure.
Coral Trials: A personal experience that challenges its results in patients with uncontrolled blood pressure.. Dr. Javier Ruiz Aburto, FACS, FICS Assistant Professor Ponce School of Medicine Puerto Rico
More informationCardiac Pathophysiology
Cardiac Pathophysiology Evaluation Components Medical history Physical examination Routine laboratory tests Optional tests Medical History Duration and classification of hypertension. Patient history of
More information7/7/ CHD/MI LVH and LV dysfunction Dysrrhythmias Stroke PVD Renal insufficiency and failure Retinopathy. Normal <120 Prehypertension
Prevalence of Hypertension Hypertension: Diagnosis and Management T. Villela, M.D. Program Director University of California, San Francisco-San Francisco General Hospital Family and Community Medicine
More informationAngina pectoris due to coronary atherosclerosis : Atenolol is indicated for the long term management of patients with angina pectoris.
Lonet Tablet Description Lonet contains Atenolol, a synthetic β1 selective (cardioselective) adrenoreceptor blocking agent without membrane stabilising or intrinsic sympathomimetic (partial agonist) activity.
More informationCHALLENGES OF HYPERTENSION IN THE COALFACE
CHALLENGES OF HYPERTENSION IN THE COALFACE Y VERIAVA CENTRE FOR RURAL HEALTH SCHOOL OF CLINICAL MEDICINE FACULTY OF HEALTH SCIENCES UNIVERSITY OF WITWATERSRAND SYSTOLIC AND DIASTOLIC BLOOD PRESSURES (BP)
More informationBlood pressure changes in acute ischemic stroke and outcome with respect to stroke etiology
Blood pressure changes in acute ischemic stroke and outcome with respect to stroke etiology G. Ntaios, MD D. Lambrou, PhD P. Michel, MD Correspondence & reprint requests to Dr. Ntaios: gntaios@med.uth.gr
More informationA very short lecture.
Medical Treatment of Type A Aortic Dissection: Tales of Turkeys, Tygon Tubing, and Evolving Paradigms The Houston Aortic Symposium April 4-6, 2008 John A. Elefteriades, MD William W.L. Glenn Professor
More informationHeart Failure Update John Coyle, M.D.
Heart Failure Update 2011 John Coyle, M.D. Causes of Heart Failure Anderson,B.Am Heart J 1993;126:632-40 It It is now well-established that at least one-half of the patients presenting with symptoms and
More information- Dr Alia Shatnawi. 1 P a g e
- 1 مها أبو عجمية - - - Dr Alia Shatnawi 1 P a g e A Skippable Intr0 Blood pressure normally decreases during the night. Absence of this phenomenon is called (nondipping) Wikipedia: Circadian rhythm....
More informationMedical Management of Acute Heart Failure
Critical Care Medicine and Trauma Medical Management of Acute Heart Failure Mary O. Gray, MD, FAHA Associate Professor of Medicine University of California, San Francisco Staff Cardiologist and Training
More informationHYPERTENSION: Sustained elevation of arterial blood pressure above normal o Systolic 140 mm Hg and/or o Diastolic 90 mm Hg
Lecture 39 Anti-Hypertensives B-Rod BLOOD PRESSURE: Systolic / Diastolic NORMAL: 120/80 Systolic = measure of pressure as heart is beating Diastolic = measure of pressure while heart is at rest between
More informationHypertension. Most important public health problem in developed countries
Hypertension Strategy for Continued Success in Treatment for the 21st Century November 15, 2005 Arnold B. Meshkov, M.D. Associate Professor of Medicine Temple University School of Medicine Philadelphia,
More informationMANAGEMENT OF HYPERTENSION IN PREGNANCY, THE ALGORHITHM
MANAGEMENT OF HYPERTENSION IN PREGNANCY, THE ALGORHITHM Are Particular Anti-hypertensives More Effective or Harmful Than Others in Hypertension in Pregnancy? Existing data is inadequate Methyldopa and
More informationIn the name of GOD. Animal models of cardiovascular diseases: myocardial infarction & hypertension
In the name of GOD Animal models of cardiovascular diseases: myocardial infarction & hypertension 44 Presentation outline: Cardiovascular diseases Acute myocardial infarction Animal models for myocardial
More informationEndocrine. Endocrine as it relates to the kidney. Sarah Elfering, MD University of Minnesota
Endocrine Sarah Elfering, MD University of Minnesota Endocrine as it relates to the kidney Parathyroid gland Vitamin D Endocrine causes of HTN Adrenal adenoma PTH Bone Kidney Intestine 1, 25 OH Vitamin
More informationKlinikum Frankfurt Höchst
Blood pressure management in hemorrhagic stroke Blood pressure in acute ICH Do we need additional trials after INTERACT2 and ATTACH-II? Focus.de Department of Neurology,, Germany Department of Neurology,
More informationSBP in range of 120 to 140 :no progression or regression of CAD. Sipahi et al., 2006
Management of Hypertension in Patients with CAD M. Mohsen Ibrahim, MD Cardiology Department- Cairo University 1. What is the optimal BP in patients with hypertension and CAD? 2. What is the minimum safe
More informationCandesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients
1/5 This site became the new ClinicalTrials.gov on June 19th. Learn more. We will be updating this site in phases. This allows us to move faster and to deliver better services. Show less IMPORTANT: Listing
More informationHypertension. Penny Mosley MRPharmS
Hypertension Penny Mosley MRPharmS Outline of presentation Introduction to hypertension Physiological control of arterial blood pressure What determines our bp? What determines the heart rate? What determines
More informationPolicy REVISED: 6/30/2016 3:30 PM. Applies To: ObGyn Responsible Department: ObGyn Revised: June 30, 2016
Title: Antihypertensive Treatment for Severe Hypertension During Pregnancy Applies To: ObGyn Responsible Department: ObGyn Revised: June 30, 2016 Policy POLICY STATEMENT: Pregnant or postpartum patients
More informationSystemic Hypertension
BCS Theme Session Cardiovascular Block Pathology of Hypertension Department of Pathology University of Sydney Systemic Hypertension Definition of Systemic hypertension: consistent blood pressure elevation
More informationLXIV: DRUGS: 4. RAS BLOCKADE
LXIV: DRUGS: 4. RAS BLOCKADE ACE Inhibitors Components of RAS Actions of Angiotensin i II Indications for ACEIs Contraindications RAS blockade in hypertension RAS blockade in CAD RAS blockade in HF Limitations
More informationBlood Vessels. Dr. Nabila Hamdi MD, PhD
Blood Vessels Dr. Nabila Hamdi MD, PhD ILOs Understand the structure and function of blood vessels. Discuss the different mechanisms of blood pressure regulation. Compare and contrast the following types
More informationRegulation of Arterial Blood Pressure 2 George D. Ford, Ph.D.
Regulation of Arterial Blood Pressure 2 George D. Ford, Ph.D. OBJECTIVES: 1. Describe the Central Nervous System Ischemic Response. 2. Describe chemical sensitivities of arterial and cardiopulmonary chemoreceptors,
More informationAntihypertensives. Diagnostic category
Measurement of blood pressure At first assessment, take both arms then choose the one with the higher reading. Beware of orthostatic hypotension. Measure BP in sitting position, and repeat after patient
More informationCardiovascular Disorders Lecture 3 Coronar Artery Diseases
Cardiovascular Disorders Lecture 3 Coronar Artery Diseases By Prof. El Sayed Abdel Fattah Eid Lecturer of Internal Medicine Delta University Coronary Heart Diseases It is the leading cause of death in
More informationFAILURE IN PATIENTS WITH MYOCARDIAL INFARCTION
Br. J. clin. Pharmac. (1982), 14, 187S-19lS BENEFICIAL EFFECTS OF CAPTOPRIL IN LEFT VENTRICULAR FAILURE IN PATIENTS WITH MYOCARDIAL INFARCTION J.P. BOUNHOURE, J.G. KAYANAKIS, J.M. FAUVEL & J. PUEL Departments
More informationHypertension Update. Objectives 4/28/2015. Beverly J. Mathis, D.O. OOA May 2015
Hypertension Update Beverly J. Mathis, D.O. OOA May 2015 Objectives Learn new recommendations for BP treatment goals Approach to hypertension in the office Use of hypertensive drugs, and how to tailor
More informationHYPERTENSIVE VASCULAR DISEASE
HYPERTENSIVE VASCULAR DISEASE Cutoffs in diagnosing hypertension in clinical practice sustained diastolic pressures >90 mm Hg, or sustained systolic pressures >140 mm Hg Malignant hypertension A small
More informationMedical Management of Acutely Decompensated Heart Failure. William T. Abraham, MD Director, Division of Cardiovascular Medicine
Medical Management of Acutely Decompensated Heart Failure William T. Abraham, MD Director, Division of Cardiovascular Medicine Orlando, Florida October 7-9, 2011 Goals of Acute Heart Failure Therapy Alleviate
More informationANTI- HYPERTENSIVE AGENTS
CLINICAL ANTI- HYPERTENSIVE AGENTS Jacqueline van Schoor, MPharm, BSc (Hons) Amayeza Info Centre Hypertension represents a major public health concern. It affects about a billion people worldwide and is
More informationCirculation. Blood Pressure and Antihypertensive Medications. Venous Return. Arterial flow. Regulation of Cardiac Output.
Circulation Blood Pressure and Antihypertensive Medications Two systems Pulmonary (low pressure) Systemic (high pressure) Aorta 120 mmhg Large arteries 110 mmhg Arterioles 40 mmhg Arteriolar capillaries
More informationAngina Pectoris Dr. Shariq Syed
Angina Pectoris Dr. Syed 1 What is Angina Pectoris (AP)? Commonly known as angina is chest pain often due to ischemia of the heart muscle, Because of obstruction or spasm of the coronary arteries 2 What
More informationPHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD 5 mg/ ml THERAPEUTIC CLASSIFICATION Alpha-adrenoreceptor Blocker
PACKAGE INSERT Pr PHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD 5 mg/ ml THERAPEUTIC CLASSIFICATION Alpha-adrenoreceptor Blocker ACTIONS AND CLINICAL PHARMACOLOGY Phentolamine produces an alpha-adrenergic
More informationChildren with Hypertension in ED
Children with Hypertension in ED By Prof. Sanaa AK Helmy Professor of Anesthesia, Intensive Care and Pain Management, Faculty of Medicine, Cairo University Vice-chairman of the Egyptian Society of Emergency
More informationP-RMS: IE/H/PSUR/0014/002
Core Safety Profile Active substance: Nitroglycerin Pharmaceutical form(s)/strength: Transdermal patch 25mg, 50mg, 75mg (corresponding to 5, 10 and 15mg per 24 hours respectively P-RMS: IE/H/PSUR/0014/002
More informationBlood Pressure Regulation 2. Faisal I. Mohammed, MD,PhD
Blood Pressure Regulation 2 Faisal I. Mohammed, MD,PhD 1 Objectives Outline the intermediate term and long term regulators of ABP. Describe the role of Epinephrine, Antidiuretic hormone (ADH), Renin-Angiotensin-Aldosterone
More informationBlood Pressure Regulation 2. Faisal I. Mohammed, MD,PhD
Blood Pressure Regulation 2 Faisal I. Mohammed, MD,PhD 1 Objectives Outline the intermediate term and long term regulators of ABP. Describe the role of Epinephrine, Antidiuretic hormone (ADH), Renin-Angiotensin-Aldosterone
More information11/27/2017. Stroke Management in the Neurocritical Care Unit. Conflict of interest. Karel Fuentes MD Medical Director of Neurocritical Care
Stroke Management in the Neurocritical Care Unit Karel Fuentes MD Medical Director of Neurocritical Care Conflict of interest None Introduction Reperfusion therapy remains the mainstay in the treatment
More informationPreventing the cardiovascular complications of hypertension
European Heart Journal Supplements (2004) 6 (Supplement H), H37 H42 Preventing the cardiovascular complications of hypertension Peter Trenkwalder* Department of Internal Medicine, Starnberg Hospital, Ludwig
More informationChapter (9) Calcium Antagonists
Chapter (9) Calcium Antagonists (CALCIUM CHANNEL BLOCKERS) Classification Mechanism of Anti-ischemic Actions Indications Drug Interaction with Verapamil Contraindications Adverse Effects Treatment of Drug
More informationData Alert #2... Bi o l o g y Work i n g Gro u p. Subject: HOPE: New validation for the importance of tissue ACE inhibition
Vascular Bi o l o g y Work i n g Gro u p c/o Medical Education Consultants, In c. 25 Sy l van Road South, We s t p o rt, CT 06880 Chairman: Carl J. Pepine, MD Professor and Chief Division of Cardiovascular
More informationPharmacology. Drugs affecting the Cardiovascular system (Antianginal Drugs)
Lecture 7 (year3) Dr Noor Al-Hasani Pharmacology University of Baghdad College of dentistry Drugs affecting the Cardiovascular system (Antianginal Drugs) Atherosclerotic disease of the coronary arteries,
More informationHYPERTENSION. Background for understanding the Hypertension literature. Case presentation. Approach to Treatment. Jeffrey J. Kaufhold, MD Nephrology
HYPERTENSION Background for understanding the Hypertension literature. Case presentation Approach to Treatment Jeffrey J. Kaufhold, MD Nephrology 2009 HYPERTENSION SUMMARY Background for understanding
More informationManagement of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine
Management of Hypertension M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine Disturbing Trends in Hypertension HTN awareness, treatment and control rates are decreasing
More informationΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH
ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH Hypertension Co-Morbidities HTN Commonly Clusters with Other Risk
More informationHow Low Should You Go? Management of Blood Pressure in Intracranial Hemorrhage
How Low Should You Go? Management of Blood Pressure in Intracranial Hemorrhage Rachael Scott, Pharm.D. PGY2 Critical Care Pharmacy Resident Pharmacy Grand Rounds August 21, 2018 2018 MFMER slide-1 Patient
More informationAntihypertensive Agents
Antihypertensive Agents Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 7, 08, presented by Ezra Levy, Pharm.D! Usual Dose,
More information(D) (E) (F) 6. The extrasystolic beat would produce (A) increased pulse pressure because contractility. is increased. increased
Review Test 1. A 53-year-old woman is found, by arteriography, to have 5% narrowing of her left renal artery. What is the expected change in blood flow through the stenotic artery? Decrease to 1 2 Decrease
More informationFranklin Delano Roosevelt. Learning Objectives. Severe hypertension is relatively common. Current State of Hypertensive Crisis Management
3 3:45 pm Presenter Disclosure Information What Every Primary Care Clinician Needs to Know about Hypertension Crises SPEAKER Karol E. Watson, MD, PhD, FACC The following relationships exist related to
More informationHEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM
REVIEW DATE REVIEWER'S ID HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM : DISCHARGE DATE: RECORDS FROM: Hospitalization ER Please check all that may apply: Myocardial Infarction Pages 2, 3,
More informationHTN of pregnancy is serious and must be controlled, because without monitoring it can develop into pre-eclampsia and finally to eclampsia.
Sheet Pharmacology #7 1 Antihypertensive drugs of pregnancy: ببسسممم الله االرححممننن االرححيممم Usage of normal drugs of chronic HTN is controversial in pregnancy, because after few weeks or second trimester,
More informationHeart Failure. Subjective SOB (shortness of breath) Peripheral edema. Orthopnea (2-3 pillows) PND (paroxysmal nocturnal dyspnea)
Pharmacology I. Definitions A. Heart Failure (HF) Heart Failure Ezra Levy, Pharm.D. HF Results when one or both ventricles are unable to pump sufficient blood to meet the body s needs There are 2 types
More informationIndex. Note: Page numbers of article titles are in boldface type.
Heart Failure Clin 2 (2006) 101 105 Index Note: Page numbers of article titles are in boldface type. A ACE inhibitors, in diabetic hypertension, 30 31 Adipokines, cardiovascular events related to, 6 Advanced
More informationReview Article Unsolved Issues in the Management of High Blood Pressure in Acute Ischemic Stroke
International Hypertension Volume 2013, Article ID 349782, 5 pages http://dx.doi.org/10.1155/2013/349782 Review Article Unsolved Issues in the Management of High Blood Pressure in Acute Ischemic Stroke
More informationChapter 10 Worksheet Blood Pressure and Antithrombotic Agents
Complete the following. 1. A layer of cells lines each vessel in the vascular system. This layer is a passive barrier that keeps cells and proteins from going into tissues; it also contains substances
More informationHypertension The normal radial artery blood pressures in adults are: Systolic arterial pressure: 100 to 140 mmhg. Diastolic arterial pressure: 60 to
Hypertension The normal radial artery blood pressures in adults are: Systolic arterial pressure: 100 to 140 mmhg. Diastolic arterial pressure: 60 to 90 mmhg. These pressures are called Normal blood pressure
More informationINDEX. Index 517. A AASK, see African-American Study of Kidney Disease ACE inhibitors, see Angiotensinconverting
Index 517 INDEX A AASK, see African-American Study of Kidney Disease ACE inhibitors, see Angiotensinconverting enzyme inhibitors ACS, see Acute coronary syndrome Acute coronary syndrome (ACS), classification
More informationMedical Treatment for acute Decompensated Heart Failure. Vlasis Ninios Cardiologist St. Luke s s Hospital Thessaloniki 2011
Medical Treatment for acute Decompensated Heart Failure Vlasis Ninios Cardiologist St. Luke s s Hospital Thessaloniki 2011 2010 HFSA guidelines for ADHF 2009 focused update of the 2005 American College
More informationInnovation therapy in Heart Failure
Innovation therapy in Heart Failure P. Laothavorn September 2015 Topics of discussion Basic Knowledge about heart failure Standard therapy New emerging therapy References: standard Therapy in Heart Failure
More informationAmlodipine plus Lisinopril Tablets AMLOPRES-L
Amlodipine plus Lisinopril Tablets AMLOPRES-L COMPOSITION AMLOPRES-L Each uncoated tablet contains: Amlodipine besylate equivalent to Amlodipine 5 mg and Lisinopril USP equivalent to Lisinopril (anhydrous)
More informationAntihypertensive Agents
Antihypertensive Agents Öner Süzer www.onersuzer.com osuzer@istanbul.edu.tr Last update: 13.11.2009 1 Süzer Farmakoloji 3. Baskı 2005 2 1 Süzer Farmakoloji 3. Baskı 2005 3 Süzer Farmakoloji 3. Baskı 2005
More informationJNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults
JNC 8 2014 Evidence-Based Guidelines for the Management of High Blood Pressure in Adults Table of Contents Why Do We Treat Hypertension? Blood Pressure Treatment Goals Initial Therapy Strength of Recommendation
More informationβ adrenergic blockade, a renal perspective Prof S O McLigeyo
β adrenergic blockade, a renal perspective Prof S O McLigeyo Carvedilol Third generation β blocker (both β 1 and β 2 ) Possesses α 1 adrenergic blocking properties. β: α blocking ratio 7:1 to 3:1 Antioxidant
More informationEgyptian Hypertension Guidelines
Egyptian Hypertension Guidelines 2014 Egyptian Hypertension Guidelines Dalia R. ElRemissy, MD Lecturer of Cardiovascular Medicine Cairo University Why Egyptian Guidelines? Guidelines developed for rich
More informationThe problem of uncontrolled hypertension
(2002) 16, S3 S8 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh The problem of uncontrolled hypertension Department of Public Health and Clinical Medicine, Norrlands
More information